BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · IEX Real-Time Price · USD
4.500
-0.080 (-1.75%)
At close: Apr 18, 2024, 4:00 PM
4.600
+0.100 (2.22%)
After-hours: Apr 18, 2024, 7:59 PM EDT
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of $927.68 million as of April 18, 2024. Its market cap has decreased by -42.09% in one year.
Market Cap
927.68M
Enterprise Value
1.39B
1-Year Change
-42.09%
Ranking
Category
Stock Price
$4.50
Market Cap Chart
Since December 1, 1998, BioCryst Pharmaceuticals's market cap has increased from $100.40M to $927.68M, an increase of 823.98%. That is a compound annual growth rate of 9.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 944.20M | -0.65% |
| Apr 16, 2024 | 950.40M | -1.28% |
| Apr 15, 2024 | 962.70M | -2.09% |
| Apr 12, 2024 | 983.30M | -6.48% |
| Apr 11, 2024 | 1.05B | 4.72% |
| Apr 10, 2024 | 1.00B | 1.47% |
| Apr 9, 2024 | 989.50M | 4.11% |
| Apr 8, 2024 | 950.40M | 0.22% |
| Apr 5, 2024 | 948.30M | - |
| Apr 4, 2024 | 948.30M | -2.75% |
| Apr 3, 2024 | 975.10M | 0.86% |
| Apr 2, 2024 | 966.80M | -7.14% |
| Apr 1, 2024 | 1.04B | -0.58% |
| Mar 28, 2024 | 1.05B | -1.37% |
| Mar 27, 2024 | 1.06B | 2.80% |
| Mar 26, 2024 | 1.03B | 2.04% |
| Mar 25, 2024 | 1.01B | -1.99% |
| Mar 22, 2024 | 1.03B | -8.75% |
| Mar 21, 2024 | 1.13B | 0.37% |
| Mar 20, 2024 | 1.13B | 2.05% |
| Mar 19, 2024 | 1.11B | 5.72% |
| Mar 18, 2024 | 1.05B | 1.41% |
| Mar 15, 2024 | 1.03B | 2.24% |
| Mar 14, 2024 | 1.01B | -4.86% |
| Mar 13, 2024 | 1.06B | - |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Standard BioTools | 972.94M |
| Alignment Healthcare | 972.35M |
| Viridian Therapeutics | 951.56M |
| Abivax | 950.68M |
| Innoviva | 928.81M |
| Bicycle Therapeutics | 923.22M |
| Cronos Group | 918.93M |
| Cassava Sciences | 915.94M |